Companies: 10,305     total market cap: NZ$201.227 T
🇩🇪 Deutsch🇫🇷 Français
$USD🇺🇸€EUR🇪🇺₹INR🇮🇳£GBP🇬🇧$CAD🇨🇦$AUD🇦🇺$HKD🇭🇰$SGD🇸🇬
Catalent
CTLT
#1491
Rank
NZ$20.48 B
Marketcap
🇺🇸 United States
Country
$112.84
Share price
0.00%
Change (1 day)
57.47%
Change (1 year)
💊 Pharmaceuticals🧬 Biotech
Categories
Catalent is an American pharmaceutical contract research and development company.

P/S ratio for Catalent (CTLT)

P/S ratio as of December 2024 (TTM): 2.61

According to Catalent's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.25. At the end of 2024 the company had a P/S ratio of 2.48.

P/S ratio history for Catalent from 2014 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20242.4825%
20231.9816.31%
20221.70-66.69%
20215.113.35%
20204.9563.79%
20193.0265.48%
20181.82-23.1%
20172.3733.8%
20161.774.41%
20151.70-9.11%
20141.87

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Supernus Pharmaceuticals
SUPN
3.12 19.73%🇺🇸 USA
Aerie Pharmaceuticals
AERI
3.52 35.19%🇺🇸 USA
Jazz Pharmaceuticals
JAZZ
1.90-27.24%🇮🇪 Ireland
Intercept Pharmaceuticals
ICPT
2.50-4.00%🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2024 CompaniesMarketcap.com